Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Proc Natl Acad Sci U S A ; 115(3): E498-E505, 2018 01 16.
Article in English | MEDLINE | ID: mdl-29295936

ABSTRACT

STAT3 is constitutively activated in many cancers and regulates gene expression to promote cancer cell survival, proliferation, invasion, and migration. In diffuse large B cell lymphoma (DLBCL), activation of STAT3 and its kinase JAK1 is caused by autocrine production of IL-6 and IL-10 in the activated B cell-like subtype (ABC). However, the gene regulatory mechanisms underlying the pathogenesis of this aggressive lymphoma by STAT3 are not well characterized. Here we performed genome-wide analysis and identified 2,251 STAT3 direct target genes, which involve B cell activation, survival, proliferation, differentiation, and migration. Whole-transcriptome profiling revealed that STAT3 acts as both a transcriptional activator and a suppressor, with a comparable number of up- and down-regulated genes. STAT3 regulates multiple oncogenic signaling pathways, including NF-κB, a cell-cycle checkpoint, PI3K/AKT/mTORC1, and STAT3 itself. In addition, STAT3 negatively regulates the lethal type I IFN signaling pathway by inhibiting expression of IRF7, IRF9, STAT1, and STAT2 Inhibition of STAT3 activity by ruxolitinib synergizes with the type I IFN inducer lenalidomide in growth inhibition of ABC DLBCL cells in vitro and in a xenograft mouse model. Therefore, this study provides a mechanistic rationale for clinical trials to evaluate ruxolitinib or a specific JAK1 inhibitor combined with lenalidomide in ABC DLBCL.


Subject(s)
Gene Expression Regulation, Neoplastic/drug effects , Interferon Type I/metabolism , Lymphoma, Large B-Cell, Diffuse/metabolism , Pyrazoles/pharmacology , STAT3 Transcription Factor/metabolism , Signal Transduction/physiology , Cell Differentiation , Cell Line, Tumor , Cell Movement , Cell Proliferation , Cell Survival , Cytokines/genetics , Cytokines/metabolism , Genome-Wide Association Study , Humans , Immunologic Factors/administration & dosage , Immunologic Factors/pharmacology , Interferon Type I/genetics , Lenalidomide , Nitriles , Pyrazoles/administration & dosage , Pyrimidines , STAT3 Transcription Factor/antagonists & inhibitors , STAT3 Transcription Factor/genetics , Thalidomide/administration & dosage , Thalidomide/analogs & derivatives , Thalidomide/pharmacology
2.
Biochemistry ; 59(16): 1565-1581, 2020 04 28.
Article in English | MEDLINE | ID: mdl-32216369

ABSTRACT

FRET (fluorescence resonance energy transfer) between far-upstream (-100) and downstream (+14) cyanine dyes (Cy3, Cy5) showed extensive bending and wrapping of λPR promoter DNA on Escherichia coli RNA polymerase (RNAP) in closed and open complexes (CC and OC, respectively). Here we determine the kinetics and mechanism of DNA bending and wrapping by FRET and of formation of RNAP contacts with -100 and +14 DNA by single-dye protein-induced fluorescence enhancement (PIFE). FRET and PIFE kinetics exhibit two phases: rapidly reversible steps forming a CC ensemble ({CC}) of four intermediates [initial (RPC), early (I1E), mid (I1M), and late (I1L)], followed by conversion of {CC} to OC via I1L. FRET and PIFE are first observed for I1E, not RPc. FRET and PIFE together reveal large-scale bending and wrapping of upstream and downstream DNA as RPC advances to I1E, decreasing the Cy3-Cy5 distance to ∼75 Å and making RNAP-DNA contacts at -100 and +14. We propose that far-upstream DNA wraps on the upper ß'-clamp while downstream DNA contacts the top of the ß-pincer in I1E. Converting I1E to I1M (∼1 s time scale) reduces FRET efficiency with little change in -100 or +14 PIFE, interpreted as clamp opening that moves far-upstream DNA (on ß') away from downstream DNA (on ß) to increase the Cy3-Cy5 distance by ∼14 Å. FRET increases greatly in converting I1M to I1L, indicating bending of downstream duplex DNA into the clamp and clamp closing to reduce the Cy3-Cy5 distance by ∼21 Å. In the subsequent rate-determining DNA-opening step, in which the clamp may also open, I1L is converted to the initial unstable OC (I2). Implications for facilitation of CC-to-OC isomerization by upstream DNA and upstream binding, DNA-bending transcription activators are discussed.


Subject(s)
DNA-Directed RNA Polymerases/metabolism , DNA/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli/enzymology , Carbocyanines/chemistry , DNA/chemistry , DNA/genetics , DNA-Directed RNA Polymerases/chemistry , Escherichia coli Proteins/chemistry , Fluorescence , Fluorescence Resonance Energy Transfer , Fluorescent Dyes/chemistry , Kinetics , Nucleic Acid Conformation , Promoter Regions, Genetic , Protein Binding
3.
Proc Natl Acad Sci U S A ; 113(46): E7260-E7267, 2016 11 15.
Article in English | MEDLINE | ID: mdl-27799566

ABSTRACT

Janus kinases (JAKs) classically signal by activating STAT transcription factors but can also regulate gene expression by epigenetically phosphorylating histone H3 on tyrosine 41 (H3Y41-P). In diffuse large B-cell lymphomas (DLBCLs), JAK signaling is a feature of the activated B-cell (ABC) subtype and is triggered by autocrine production of IL-6 and IL-10. Whether this signaling involves STAT activation, epigenetic modification of chromatin, or both mechanisms is unknown. Here we use genetic and pharmacological inhibition to show that JAK1 signaling sustains the survival of ABC DLBCL cells. Whereas STAT3 contributed to the survival of ABC DLBCL cell lines, forced STAT3 activity could not protect these cells from death following JAK1 inhibition, suggesting epigenetic JAK1 action. JAK1 regulated the expression of nearly 3,000 genes in ABC DLBCL cells, and the chromatin surrounding many of these genes was modified by H3Y41-P marks that were diminished by JAK1 inhibition. These JAK1 epigenetic target genes encode important regulators of ABC DLBCL proliferation and survival, including IRF4, MYD88, and MYC. A small molecule JAK1 inhibitor cooperated with the BTK inhibitor ibrutinib in reducing IRF4 levels and acted synergistically to kill ABC DLBCL cells, suggesting that this combination should be evaluated in clinical trials.


Subject(s)
Janus Kinase 1/genetics , Lymphoma, Large B-Cell, Diffuse/genetics , Apoptosis , Cell Line, Tumor , Epigenesis, Genetic , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Humans , Janus Kinase 1/antagonists & inhibitors , STAT3 Transcription Factor/genetics
4.
Biochemistry ; 51(47): 9447-59, 2012 Nov 27.
Article in English | MEDLINE | ID: mdl-23116321

ABSTRACT

Differences in kinetics of transcription initiation by RNA polymerase (RNAP) at different promoters tailor the pattern of gene expression to cellular needs. After initial binding, large conformational changes occur in promoter DNA and RNAP to form initiation-capable complexes. To understand the mechanism and regulation of transcription initiation, the nature and sequence of these conformational changes must be determined. Escherichia coli RNAP uses binding free energy to unwind and separate 13 base pairs of λP(R) promoter DNA to form the unstable open intermediate I(2), which rapidly converts to much more stable open complexes (I(3), RP(o)). Conversion of I(2) to RP(o) involves folding/assembly of several mobile RNAP domains on downstream duplex DNA. Here, we investigate effects of a 42-residue deletion in the mobile ß' jaw (ΔJAW) and truncation of promoter DNA beyond +12 (DT+12) on the steps of initiation. We find that in stable ΔJAW open complexes the downstream boundary of hydroxyl radical protection shortens by 5-10 base pairs, as compared to wild-type (WT) complexes. Dissociation kinetics of open complexes formed with ΔJAW RNAP and/or DT+12 DNA resemble those deduced for the structurally uncharacterized intermediate I(3). Overall rate constants (k(a)) for promoter binding and DNA opening by ΔJAW RNAP are much smaller than for WT RNAP. Values of k(a) for WT RNAP with DT+12 and full-length λP(R) are similar, though contributions of binding and isomerization steps differ. Hence, the jaw plays major roles both early and late in RP(o) formation, while downstream DNA functions primarily as the assembly platform after DNA opening.


Subject(s)
DNA-Directed RNA Polymerases/metabolism , Transcription Initiation, Genetic/physiology , Catalytic Domain , DNA, Bacterial/metabolism , DNA-Directed RNA Polymerases/chemistry , Escherichia coli/enzymology , Kinetics , Models, Molecular , Nucleic Acid Conformation , Promoter Regions, Genetic , Protein Conformation
5.
Mol Biol Cell ; 30(12): 1505-1522, 2019 06 01.
Article in English | MEDLINE | ID: mdl-30969903

ABSTRACT

Centrosomes and spindle pole bodies (SPBs) are membraneless organelles whose duplication and assembly is necessary for bipolar mitotic spindle formation. The structural organization and functional roles of major proteins in these organelles can provide critical insights into cell division control. Spc42, a phosphoregulated protein with an N-terminal dimeric coiled-coil (DCC), assembles into a hexameric array at the budding yeast SPB core, where it functions as a scaffold for SPB assembly. Here, we present in vitro and in vivo data to elucidate the structural arrangement and biological roles of Spc42 elements. Crystal structures reveal details of two additional coiled-coils in Spc42: a central trimeric coiled-coil and a C-terminal antiparallel DCC. Contributions of the three Spc42 coiled-coils and adjacent undetermined regions to the formation of an ∼145 Šhexameric lattice in an in vitro lipid monolayer assay and to SPB duplication and assembly in vivo reveal structural and functional redundancy in Spc42 assembly. We propose an updated model that incorporates the inherent symmetry of these Spc42 elements into a lattice, and thereby establishes the observed sixfold symmetry. The implications of this model for the organization of the central SPB core layer are discussed.


Subject(s)
Centrosome/metabolism , Cytoskeletal Proteins/chemistry , Cytoskeletal Proteins/metabolism , Phosphoproteins/chemistry , Phosphoproteins/metabolism , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/metabolism , Conserved Sequence , Lipids/chemistry , Models, Biological , Protein Domains , Protein Multimerization , Protein Stability , Protein Structure, Secondary , Spindle Pole Bodies/metabolism , Structure-Activity Relationship
6.
Leuk Lymphoma ; 58(11): 2540-2547, 2017 11.
Article in English | MEDLINE | ID: mdl-28402164

ABSTRACT

The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is central to signaling by receptors of diverse cytokines, growth factors, and other related molecules. Many of these receptors transmit anti-apoptosis, proliferation, and differentiation signals that are critical for normal hematopoiesis and immune response. However, the JAK/STAT signaling pathway is deregulated in many hematologic malignancies, and as such is co-opted by malignant cells to promote their survival and proliferation. It has recently come to light that an alternative mechanism, wherein nuclear JAKs epigenetically modify the chromatin to increase gene expression independent of STATs, also plays an important role in the pathogenesis of many hematologic malignancies. In this review, we will focus on common genetic alterations of the JAK family members in leukemia and lymphoma, and provide examples in which JAKs regulate gene expression by targeting the cancer epigenome.


Subject(s)
Epigenesis, Genetic , Epigenomics , Janus Kinases/genetics , Leukemia/genetics , Lymphoma/genetics , Signal Transduction/genetics , Cell Survival/genetics , Gene Expression Regulation, Neoplastic , Humans , STAT Transcription Factors/genetics
7.
J Mol Biol ; 427(15): 2435-2450, 2015 Jul 31.
Article in English | MEDLINE | ID: mdl-26055538

ABSTRACT

In transcription initiation by Escherichia coli RNA polymerase (RNAP), initial binding to promoter DNA triggers large conformational changes, bending downstream duplex DNA into the RNAP cleft and opening 13bp to form a short-lived open intermediate (I2). Subsequent conformational changes increase lifetimes of λPR and T7A1 open complexes (OCs) by >10(5)-fold and >10(2)-fold, respectively. OC lifetime is a target for regulation. To characterize late conformational changes, we determine effects on OC dissociation kinetics of deletions in RNAP mobile elements σ(70) region 1.1 (σ1.1), ß' jaw and ß' sequence insertion 3 (SI3). In very stable OC formed by the wild type WT RNAP with λPR (RPO) and by Δσ1.1 RNAP with λPR or T7A1, we conclude that downstream duplex DNA is bound to the jaw in an assembly with SI3, and bases -4 to +2 of the nontemplate strand discriminator region are stably bound in a positively charged track in the cleft. We deduce that polyanionic σ1.1 destabilizes OC by competing for binding sites in the cleft and on the jaw with the polyanionic discriminator strand and downstream duplex, respectively. Examples of σ1.1-destabilized OC are the final T7A1 OC and the λPR I3 intermediate OC. Deleting σ1.1 and either ß' jaw or SI3 equalizes OC lifetimes for λPR and T7A1. DNA closing rates are similar for both promoters and all RNAP variants. We conclude that late conformational changes that stabilize OC, like early ones that bend the duplex into the cleft, are primary targets of regulation, while the intrinsic DNA opening/closing step is not.


Subject(s)
DNA-Directed RNA Polymerases/chemistry , Escherichia coli/enzymology , Base Sequence , Binding Sites/genetics , DNA, Bacterial/chemistry , DNA, Bacterial/metabolism , DNA-Directed RNA Polymerases/genetics , Escherichia coli/genetics , Models, Molecular , Molecular Sequence Data , Multiprotein Complexes/chemistry , Multiprotein Complexes/metabolism , Nucleic Acid Conformation , Promoter Regions, Genetic , Protein Binding , Sigma Factor/chemistry , Sigma Factor/genetics , Sigma Factor/metabolism , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL